Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004621046 | SCV005113138 | uncertain significance | not specified | 2024-05-24 | criteria provided, single submitter | clinical testing | The c.962A>G (p.N321S) alteration is located in exon 8 (coding exon 8) of the FBLN7 gene. This alteration results from a A to G substitution at nucleotide position 962, causing the asparagine (N) at amino acid position 321 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |